Carole Longson is to join the Association of the British Pharmaceutical Industry as its chief scientific officer.
Longson will move from the National Institute for Health and Care Excellence (NICE), where she has worked for 17 years. She is currently director of the Centre for Health Technology Evaluation and a NICE board member.
In her new role, Longson will be responsible for the ABPI research, medical and innovation function, with a remit to shape and develop UK pharmaceutical science policy. She has a doctorate in pharmacology and her career includes eight years as research lead at GlaxoSmithKline Research working on the development of novel pharmaceuticals.
She is a past member of the Scientific Committee for the Innovative Medicines Initiative, and also holds non-executive director and advisory roles in the UK and abroad.
Longson has stepped down from her current responsibilities at NICE and will leave on 12 April.